AVTR - Biotechnology Company Avantor Aligns Business Segments Eyes Cost Savings | Benzinga
At the investor day, Avantor Inc (NYSE: AVTR) announced its plans to transform the business by implementing a new operating model and launching a multi-year cost optimization initiative.
Segment Change: As per the new model, Avantor plans to transition to two complementary business segments from three geographic segments - Laboratory Solutions and Bioscience Production.
Michael Stubblefield, President and Chief Executive Officer, said, "Aligning our model with our research and production capabilities ...